img

Global Spinal Muscular Atrophy Medicine Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Spinal Muscular Atrophy Medicine Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Spinal Muscular Atrophy Medicine report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Spinal Muscular Atrophy Medicine market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospital and Clinic are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Spinal Muscular Atrophy Medicine industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Spinal Muscular Atrophy Medicine key manufacturers include Astellas Pharma Inc., AveXis, Inc., Bioblast Pharma Ltd., Cytokinetics, Inc. 24, F. Hoffmann-La Roche Ltd., Genethon, Genzyme Corporation, GMP-Orphan SAS and Ionis Pharmaceuticals, Inc., etc. Astellas Pharma Inc., AveXis, Inc., Bioblast Pharma Ltd. are top 3 players and held % sales share in total in 2022.
Spinal Muscular Atrophy Medicine can be divided into LMI-070, ND-602, NT-1654 and Nusinersen, etc. LMI-070 is the mainstream product in the market, accounting for % sales share globally in 2022.
Spinal Muscular Atrophy Medicine is widely used in various fields, such as Hospital, Clinic and Others,, etc. Hospital provides greatest supports to the Spinal Muscular Atrophy Medicine industry development. In 2022, global % sales of Spinal Muscular Atrophy Medicine went into Hospital filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Spinal Muscular Atrophy Medicine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Astellas Pharma Inc.
AveXis, Inc.
Bioblast Pharma Ltd.
Cytokinetics, Inc. 24
F. Hoffmann-La Roche Ltd.
Genethon
Genzyme Corporation
GMP-Orphan SAS
Ionis Pharmaceuticals, Inc.
Longevity Biotech, Inc
Neurodyn Inc.
Neurotune AG
Novartis AG
Sarepta Therapeutics, Inc.
Voyager Therapeutics, Inc.
Vybion, Inc.
WAVE Life Sciences Ltd.
Segment by Type
LMI-070
ND-602
NT-1654
Nusinersen
NXD-30001
Others

Segment by Application


Hospital
Clinic
Others

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Spinal Muscular Atrophy Medicine market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Spinal Muscular Atrophy Medicine, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Spinal Muscular Atrophy Medicine industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Spinal Muscular Atrophy Medicine in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Spinal Muscular Atrophy Medicine introduction, etc. Spinal Muscular Atrophy Medicine Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Spinal Muscular Atrophy Medicine market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Spinal Muscular Atrophy Medicine Market Overview
1.1 Spinal Muscular Atrophy Medicine Product Overview
1.2 Spinal Muscular Atrophy Medicine Market Segment by Type
1.2.1 LMI-070
1.2.2 ND-602
1.2.3 NT-1654
1.2.4 Nusinersen
1.2.5 NXD-30001
1.2.6 Others
1.3 Global Spinal Muscular Atrophy Medicine Market Size by Type
1.3.1 Global Spinal Muscular Atrophy Medicine Market Size Overview by Type (2018-2034)
1.3.2 Global Spinal Muscular Atrophy Medicine Historic Market Size Review by Type (2018-2024)
1.3.3 Global Spinal Muscular Atrophy Medicine Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Spinal Muscular Atrophy Medicine Sales Breakdown by Type (2018-2024)
1.4.2 Europe Spinal Muscular Atrophy Medicine Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Spinal Muscular Atrophy Medicine Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Spinal Muscular Atrophy Medicine Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Spinal Muscular Atrophy Medicine Sales Breakdown by Type (2018-2024)
2 Global Spinal Muscular Atrophy Medicine Market Competition by Company
2.1 Global Top Players by Spinal Muscular Atrophy Medicine Sales (2018-2024)
2.2 Global Top Players by Spinal Muscular Atrophy Medicine Revenue (2018-2024)
2.3 Global Top Players by Spinal Muscular Atrophy Medicine Price (2018-2024)
2.4 Global Top Manufacturers Spinal Muscular Atrophy Medicine Manufacturing Base Distribution, Sales Area, Product Type
2.5 Spinal Muscular Atrophy Medicine Market Competitive Situation and Trends
2.5.1 Spinal Muscular Atrophy Medicine Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Spinal Muscular Atrophy Medicine Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Spinal Muscular Atrophy Medicine as of 2022)
2.7 Date of Key Manufacturers Enter into Spinal Muscular Atrophy Medicine Market
2.8 Key Manufacturers Spinal Muscular Atrophy Medicine Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Spinal Muscular Atrophy Medicine Status and Outlook by Region
3.1 Global Spinal Muscular Atrophy Medicine Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Spinal Muscular Atrophy Medicine Historic Market Size by Region
3.2.1 Global Spinal Muscular Atrophy Medicine Sales in Volume by Region (2018-2024)
3.2.2 Global Spinal Muscular Atrophy Medicine Sales in Value by Region (2018-2024)
3.2.3 Global Spinal Muscular Atrophy Medicine Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Spinal Muscular Atrophy Medicine Forecasted Market Size by Region
3.3.1 Global Spinal Muscular Atrophy Medicine Sales in Volume by Region (2024-2034)
3.3.2 Global Spinal Muscular Atrophy Medicine Sales in Value by Region (2024-2034)
3.3.3 Global Spinal Muscular Atrophy Medicine Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Spinal Muscular Atrophy Medicine by Application
4.1 Spinal Muscular Atrophy Medicine Market Segment by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Others
4.2 Global Spinal Muscular Atrophy Medicine Market Size by Application
4.2.1 Global Spinal Muscular Atrophy Medicine Market Size Overview by Application (2018-2034)
4.2.2 Global Spinal Muscular Atrophy Medicine Historic Market Size Review by Application (2018-2024)
4.2.3 Global Spinal Muscular Atrophy Medicine Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Spinal Muscular Atrophy Medicine Sales Breakdown by Application (2018-2024)
4.3.2 Europe Spinal Muscular Atrophy Medicine Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Spinal Muscular Atrophy Medicine Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Spinal Muscular Atrophy Medicine Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Spinal Muscular Atrophy Medicine Sales Breakdown by Application (2018-2024)
5 North America Spinal Muscular Atrophy Medicine by Country
5.1 North America Spinal Muscular Atrophy Medicine Historic Market Size by Country
5.1.1 North America Spinal Muscular Atrophy Medicine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Spinal Muscular Atrophy Medicine Sales in Volume by Country (2018-2024)
5.1.3 North America Spinal Muscular Atrophy Medicine Sales in Value by Country (2018-2024)
5.2 North America Spinal Muscular Atrophy Medicine Forecasted Market Size by Country
5.2.1 North America Spinal Muscular Atrophy Medicine Sales in Volume by Country (2024-2034)
5.2.2 North America Spinal Muscular Atrophy Medicine Sales in Value by Country (2024-2034)
6 Europe Spinal Muscular Atrophy Medicine by Country
6.1 Europe Spinal Muscular Atrophy Medicine Historic Market Size by Country
6.1.1 Europe Spinal Muscular Atrophy Medicine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Spinal Muscular Atrophy Medicine Sales in Volume by Country (2018-2024)
6.1.3 Europe Spinal Muscular Atrophy Medicine Sales in Value by Country (2018-2024)
6.2 Europe Spinal Muscular Atrophy Medicine Forecasted Market Size by Country
6.2.1 Europe Spinal Muscular Atrophy Medicine Sales in Volume by Country (2024-2034)
6.2.2 Europe Spinal Muscular Atrophy Medicine Sales in Value by Country (2024-2034)
7 Asia-Pacific Spinal Muscular Atrophy Medicine by Region
7.1 Asia-Pacific Spinal Muscular Atrophy Medicine Historic Market Size by Region
7.1.1 Asia-Pacific Spinal Muscular Atrophy Medicine Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Spinal Muscular Atrophy Medicine Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Spinal Muscular Atrophy Medicine Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Spinal Muscular Atrophy Medicine Forecasted Market Size by Region
7.2.1 Asia-Pacific Spinal Muscular Atrophy Medicine Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Spinal Muscular Atrophy Medicine Sales in Value by Region (2024-2034)
8 Latin America Spinal Muscular Atrophy Medicine by Country
8.1 Latin America Spinal Muscular Atrophy Medicine Historic Market Size by Country
8.1.1 Latin America Spinal Muscular Atrophy Medicine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Spinal Muscular Atrophy Medicine Sales in Volume by Country (2018-2024)
8.1.3 Latin America Spinal Muscular Atrophy Medicine Sales in Value by Country (2018-2024)
8.2 Latin America Spinal Muscular Atrophy Medicine Forecasted Market Size by Country
8.2.1 Latin America Spinal Muscular Atrophy Medicine Sales in Volume by Country (2024-2034)
8.2.2 Latin America Spinal Muscular Atrophy Medicine Sales in Value by Country (2024-2034)
9 Middle East and Africa Spinal Muscular Atrophy Medicine by Country
9.1 Middle East and Africa Spinal Muscular Atrophy Medicine Historic Market Size by Country
9.1.1 Middle East and Africa Spinal Muscular Atrophy Medicine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Spinal Muscular Atrophy Medicine Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Spinal Muscular Atrophy Medicine Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Spinal Muscular Atrophy Medicine Forecasted Market Size by Country
9.2.1 Middle East and Africa Spinal Muscular Atrophy Medicine Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Spinal Muscular Atrophy Medicine Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Astellas Pharma Inc.
10.1.1 Astellas Pharma Inc. Company Information
10.1.2 Astellas Pharma Inc. Introduction and Business Overview
10.1.3 Astellas Pharma Inc. Spinal Muscular Atrophy Medicine Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Astellas Pharma Inc. Spinal Muscular Atrophy Medicine Products Offered
10.1.5 Astellas Pharma Inc. Recent Development
10.2 AveXis, Inc.
10.2.1 AveXis, Inc. Company Information
10.2.2 AveXis, Inc. Introduction and Business Overview
10.2.3 AveXis, Inc. Spinal Muscular Atrophy Medicine Sales, Revenue and Gross Margin (2018-2024)
10.2.4 AveXis, Inc. Spinal Muscular Atrophy Medicine Products Offered
10.2.5 AveXis, Inc. Recent Development
10.3 Bioblast Pharma Ltd.
10.3.1 Bioblast Pharma Ltd. Company Information
10.3.2 Bioblast Pharma Ltd. Introduction and Business Overview
10.3.3 Bioblast Pharma Ltd. Spinal Muscular Atrophy Medicine Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Bioblast Pharma Ltd. Spinal Muscular Atrophy Medicine Products Offered
10.3.5 Bioblast Pharma Ltd. Recent Development
10.4 Cytokinetics, Inc. 24
10.4.1 Cytokinetics, Inc. 24 Company Information
10.4.2 Cytokinetics, Inc. 24 Introduction and Business Overview
10.4.3 Cytokinetics, Inc. 24 Spinal Muscular Atrophy Medicine Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Cytokinetics, Inc. 24 Spinal Muscular Atrophy Medicine Products Offered
10.4.5 Cytokinetics, Inc. 24 Recent Development
10.5 F. Hoffmann-La Roche Ltd.
10.5.1 F. Hoffmann-La Roche Ltd. Company Information
10.5.2 F. Hoffmann-La Roche Ltd. Introduction and Business Overview
10.5.3 F. Hoffmann-La Roche Ltd. Spinal Muscular Atrophy Medicine Sales, Revenue and Gross Margin (2018-2024)
10.5.4 F. Hoffmann-La Roche Ltd. Spinal Muscular Atrophy Medicine Products Offered
10.5.5 F. Hoffmann-La Roche Ltd. Recent Development
10.6 Genethon
10.6.1 Genethon Company Information
10.6.2 Genethon Introduction and Business Overview
10.6.3 Genethon Spinal Muscular Atrophy Medicine Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Genethon Spinal Muscular Atrophy Medicine Products Offered
10.6.5 Genethon Recent Development
10.7 Genzyme Corporation
10.7.1 Genzyme Corporation Company Information
10.7.2 Genzyme Corporation Introduction and Business Overview
10.7.3 Genzyme Corporation Spinal Muscular Atrophy Medicine Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Genzyme Corporation Spinal Muscular Atrophy Medicine Products Offered
10.7.5 Genzyme Corporation Recent Development
10.8 GMP-Orphan SAS
10.8.1 GMP-Orphan SAS Company Information
10.8.2 GMP-Orphan SAS Introduction and Business Overview
10.8.3 GMP-Orphan SAS Spinal Muscular Atrophy Medicine Sales, Revenue and Gross Margin (2018-2024)
10.8.4 GMP-Orphan SAS Spinal Muscular Atrophy Medicine Products Offered
10.8.5 GMP-Orphan SAS Recent Development
10.9 Ionis Pharmaceuticals, Inc.
10.9.1 Ionis Pharmaceuticals, Inc. Company Information
10.9.2 Ionis Pharmaceuticals, Inc. Introduction and Business Overview
10.9.3 Ionis Pharmaceuticals, Inc. Spinal Muscular Atrophy Medicine Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Ionis Pharmaceuticals, Inc. Spinal Muscular Atrophy Medicine Products Offered
10.9.5 Ionis Pharmaceuticals, Inc. Recent Development
10.10 Longevity Biotech, Inc
10.10.1 Longevity Biotech, Inc Company Information
10.10.2 Longevity Biotech, Inc Introduction and Business Overview
10.10.3 Longevity Biotech, Inc Spinal Muscular Atrophy Medicine Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Longevity Biotech, Inc Spinal Muscular Atrophy Medicine Products Offered
10.10.5 Longevity Biotech, Inc Recent Development
10.11 Neurodyn Inc.
10.11.1 Neurodyn Inc. Company Information
10.11.2 Neurodyn Inc. Introduction and Business Overview
10.11.3 Neurodyn Inc. Spinal Muscular Atrophy Medicine Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Neurodyn Inc. Spinal Muscular Atrophy Medicine Products Offered
10.11.5 Neurodyn Inc. Recent Development
10.12 Neurotune AG
10.12.1 Neurotune AG Company Information
10.12.2 Neurotune AG Introduction and Business Overview
10.12.3 Neurotune AG Spinal Muscular Atrophy Medicine Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Neurotune AG Spinal Muscular Atrophy Medicine Products Offered
10.12.5 Neurotune AG Recent Development
10.13 Novartis AG
10.13.1 Novartis AG Company Information
10.13.2 Novartis AG Introduction and Business Overview
10.13.3 Novartis AG Spinal Muscular Atrophy Medicine Sales, Revenue and Gross Margin (2018-2024)
10.13.4 Novartis AG Spinal Muscular Atrophy Medicine Products Offered
10.13.5 Novartis AG Recent Development
10.14 Sarepta Therapeutics, Inc.
10.14.1 Sarepta Therapeutics, Inc. Company Information
10.14.2 Sarepta Therapeutics, Inc. Introduction and Business Overview
10.14.3 Sarepta Therapeutics, Inc. Spinal Muscular Atrophy Medicine Sales, Revenue and Gross Margin (2018-2024)
10.14.4 Sarepta Therapeutics, Inc. Spinal Muscular Atrophy Medicine Products Offered
10.14.5 Sarepta Therapeutics, Inc. Recent Development
10.15 Voyager Therapeutics, Inc.
10.15.1 Voyager Therapeutics, Inc. Company Information
10.15.2 Voyager Therapeutics, Inc. Introduction and Business Overview
10.15.3 Voyager Therapeutics, Inc. Spinal Muscular Atrophy Medicine Sales, Revenue and Gross Margin (2018-2024)
10.15.4 Voyager Therapeutics, Inc. Spinal Muscular Atrophy Medicine Products Offered
10.15.5 Voyager Therapeutics, Inc. Recent Development
10.16 Vybion, Inc.
10.16.1 Vybion, Inc. Company Information
10.16.2 Vybion, Inc. Introduction and Business Overview
10.16.3 Vybion, Inc. Spinal Muscular Atrophy Medicine Sales, Revenue and Gross Margin (2018-2024)
10.16.4 Vybion, Inc. Spinal Muscular Atrophy Medicine Products Offered
10.16.5 Vybion, Inc. Recent Development
10.17 WAVE Life Sciences Ltd.
10.17.1 WAVE Life Sciences Ltd. Company Information
10.17.2 WAVE Life Sciences Ltd. Introduction and Business Overview
10.17.3 WAVE Life Sciences Ltd. Spinal Muscular Atrophy Medicine Sales, Revenue and Gross Margin (2018-2024)
10.17.4 WAVE Life Sciences Ltd. Spinal Muscular Atrophy Medicine Products Offered
10.17.5 WAVE Life Sciences Ltd. Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Spinal Muscular Atrophy Medicine Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Spinal Muscular Atrophy Medicine Industrial Chain Analysis
11.4 Spinal Muscular Atrophy Medicine Market Dynamics
11.4.1 Spinal Muscular Atrophy Medicine Industry Trends
11.4.2 Spinal Muscular Atrophy Medicine Market Drivers
11.4.3 Spinal Muscular Atrophy Medicine Market Challenges
11.4.4 Spinal Muscular Atrophy Medicine Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Spinal Muscular Atrophy Medicine Distributors
12.3 Spinal Muscular Atrophy Medicine Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of LMI-070
Table 2. Major Company of ND-602
Table 3. Major Company of NT-1654
Table 4. Major Company of Nusinersen
Table 5. Major Company of NXD-30001
Table 6. Major Company of Others
Table 7. Global Spinal Muscular Atrophy Medicine Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 8. Global Spinal Muscular Atrophy Medicine Sales by Type (2018-2024) & (K Pcs)
Table 9. Global Spinal Muscular Atrophy Medicine Sales Market Share in Volume by Type (2018-2024)
Table 10. Global Spinal Muscular Atrophy Medicine Sales by Type (2018-2024) & (US& Million)
Table 11. Global Spinal Muscular Atrophy Medicine Market Share in Value by Type (2018-2024)
Table 12. Global Spinal Muscular Atrophy Medicine Price by Type (2018-2024) & (USD/Pcs)
Table 13. Global Spinal Muscular Atrophy Medicine Sales by Type (2024-2034) & (K Pcs)
Table 14. Global Spinal Muscular Atrophy Medicine Sales Market Share in Volume by Type (2024-2034)
Table 15. Global Spinal Muscular Atrophy Medicine Sales by Type (2024-2034) & (US$ Million)
Table 16. Global Spinal Muscular Atrophy Medicine Sales Market Share in Value by Type (2024-2034)
Table 17. Global Spinal Muscular Atrophy Medicine Price by Type (2024-2034) & (USD/Pcs)
Table 18. North America Spinal Muscular Atrophy Medicine Sales by Type (2018-2024) & (K Pcs)
Table 19. North America Spinal Muscular Atrophy Medicine Sales by Type (2018-2024) & (US$ Million)
Table 20. Europe Spinal Muscular Atrophy Medicine Sales (K Pcs) by Type (2018-2024)
Table 21. Europe Spinal Muscular Atrophy Medicine Sales by Type (2018-2024) & (US$ Million)
Table 22. Asia-Pacific Spinal Muscular Atrophy Medicine Sales (K Pcs) by Type (2018-2024)
Table 23. Asia-Pacific Spinal Muscular Atrophy Medicine Sales by Type (2018-2024) & (US$ Million)
Table 24. Latin America Spinal Muscular Atrophy Medicine Sales (K Pcs) by Type (2018-2024)
Table 25. Latin America Spinal Muscular Atrophy Medicine Sales by Type (2018-2024) & (US$ Million)
Table 26. Middle East and Africa Spinal Muscular Atrophy Medicine Sales (K Pcs) by Type (2018-2024)
Table 27. Middle East and Africa Spinal Muscular Atrophy Medicine Sales by Type (2018-2024) & (US$ Million)
Table 28. Global Spinal Muscular Atrophy Medicine Sales by Company (2018-2024) & (K Pcs)
Table 29. Global Spinal Muscular Atrophy Medicine Sales Share by Company (2018-2024)
Table 30. Global Spinal Muscular Atrophy Medicine Revenue by Company (2018-2024) & (US$ Million)
Table 31. Global Spinal Muscular Atrophy Medicine Revenue Share by Company (2018-2024)
Table 32. Global Market Spinal Muscular Atrophy Medicine Price by Company (2018-2024) & (USD/Pcs)
Table 33. Global Spinal Muscular Atrophy Medicine Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 34. Global Spinal Muscular Atrophy Medicine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 35. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Spinal Muscular Atrophy Medicine as of 2022)
Table 36. Date of Key Manufacturers Enter into Spinal Muscular Atrophy Medicine Market
Table 37. Key Manufacturers Spinal Muscular Atrophy Medicine Product Type
Table 38. Mergers & Acquisitions, Expansion Plans
Table 39. Global Spinal Muscular Atrophy Medicine Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 40. Global Spinal Muscular Atrophy Medicine Sales by Region (2018-2024) & (K Pcs)
Table 41. Global Spinal Muscular Atrophy Medicine Sales Market Share in Volume by Region (2018-2024)
Table 42. Global Spinal Muscular Atrophy Medicine Sales by Region (2018-2024) & (US$ Million)
Table 43. Global Spinal Muscular Atrophy Medicine Sales Market Share in Value by Region (2018-2024)
Table 44. Global Spinal Muscular Atrophy Medicine Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 45. Global Spinal Muscular Atrophy Medicine Sales by Region (2024-2034) & (K Pcs)
Table 46. Global Spinal Muscular Atrophy Medicine Sales Market Share in Volume by Region (2024-2034)
Table 47. Global Spinal Muscular Atrophy Medicine Sales by Region (2024-2034) & (US$ Million)
Table 48. Global Spinal Muscular Atrophy Medicine Sales Market Share in Value by Region (2024-2034)
Table 49. Global Spinal Muscular Atrophy Medicine Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2024-2034)
Table 50. Global Spinal Muscular Atrophy Medicine Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 51. Global Spinal Muscular Atrophy Medicine Sales by Application (2018-2024) & (K Pcs)
Table 52. Global Spinal Muscular Atrophy Medicine Sales Market Share in Volume by Application (2018-2024)
Table 53. Global Spinal Muscular Atrophy Medicine Sales by Application (2018-2024) & (US$ Million)
Table 54. Global Spinal Muscular Atrophy Medicine Sales Market Share in Value by Application (2018-2024)
Table 55. Global Spinal Muscular Atrophy Medicine Price by Application (2018-2024) & (USD/Pcs)
Table 56. Global Spinal Muscular Atrophy Medicine Sales by Application (2024-2034) & (K Pcs)
Table 57. Global Spinal Muscular Atrophy Medicine Sales Market Share in Volume by Application (2024-2034)
Table 58. Global Spinal Muscular Atrophy Medicine Sales by Application (2024-2034) & (US$ Million)
Table 59. Global Spinal Muscular Atrophy Medicine Sales Market Share in Value by Application (2024-2034)
Table 60. Global Spinal Muscular Atrophy Medicine Price by Application (2024-2034) & (USD/Pcs)
Table 61. North America Spinal Muscular Atrophy Medicine Sales by Application (2018-2024) (K Pcs)
Table 62. North America Spinal Muscular Atrophy Medicine Sales by Application (2018-2024) & (US$ Million)
Table 63. Europe Spinal Muscular Atrophy Medicine Sales by Application (2018-2024) (K Pcs)
Table 64. Europe Spinal Muscular Atrophy Medicine Sales by Application (2018-2024) & (US$ Million)
Table 65. Asia-Pacific Spinal Muscular Atrophy Medicine Sales by Application (2018-2024) (K Pcs)
Table 66. Asia-Pacific Spinal Muscular Atrophy Medicine Sales by Application (2018-2024) & (US$ Million)
Table 67. Latin America Spinal Muscular Atrophy Medicine Sales by Application (2018-2024) (K Pcs)
Table 68. Latin America Spinal Muscular Atrophy Medicine Sales by Application (2018-2024) & (US$ Million)
Table 69. Middle East and Africa Spinal Muscular Atrophy Medicine Sales by Application (2018-2024) (K Pcs)
Table 70. Middle East and Africa Spinal Muscular Atrophy Medicine Sales by Application (2018-2024) & (US$ Million)
Table 71. North America Spinal Muscular Atrophy Medicine Sales by Country (2018-2024) & (K Pcs)
Table 72. North America Spinal Muscular Atrophy Medicine Sales Market Share in Volume by Country (2018-2024)
Table 73. North America Spinal Muscular Atrophy Medicine Sales by Country (2018-2024) & (US$ Million)
Table 74. North America Spinal Muscular Atrophy Medicine Sales Market Share in Value by Country (2018-2024)
Table 75. North America Spinal Muscular Atrophy Medicine Sales by Country (2024-2034) & (K Pcs)
Table 76. North America Spinal Muscular Atrophy Medicine Sales Market Share in Volume by Country (2024-2034)
Table 77. North America Spinal Muscular Atrophy Medicine Sales by Country (2024-2034) & (US$ Million)
Table 78. North America Spinal Muscular Atrophy Medicine Sales Market Share in Value by Country (2024-2034)
Table 79. Europe Spinal Muscular Atrophy Medicine Sales by Country (2018-2024) & (K Pcs)
Table 80. Europe Spinal Muscular Atrophy Medicine Sales Market Share in Volume by Country (2018-2024)
Table 81. Europe Spinal Muscular Atrophy Medicine Sales by Country (2018-2024) & (US$ Million)
Table 82. Europe Spinal Muscular Atrophy Medicine Sales Market Share in Value by Country (2018-2024)
Table 83. Europe Spinal Muscular Atrophy Medicine Sales by Country (2024-2034) & (K Pcs)
Table 84. Europe Spinal Muscular Atrophy Medicine Sales Market Share in Volume by Country (2024-2034)
Table 85. Europe Spinal Muscular Atrophy Medicine Sales by Country (2024-2034) & (US$ Million)
Table 86. Europe Spinal Muscular Atrophy Medicine Sales Market Share in Value by Country (2024-2034)
Table 87. Asia-Pacific Spinal Muscular Atrophy Medicine Sales by Region (2018-2024) & (K Pcs)
Table 88. Asia-Pacific Spinal Muscular Atrophy Medicine Sales Market Share in Volume by Region (2018-2024)
Table 89. Asia-Pacific Spinal Muscular Atrophy Medicine Sales by Region (2018-2024) & (US$ Million)
Table 90. Asia-Pacific Spinal Muscular Atrophy Medicine Sales Market Share in Value by Region (2018-2024)
Table 91. Asia-Pacific Spinal Muscular Atrophy Medicine Sales by Region (2024-2034) & (K Pcs)
Table 92. Asia-Pacific Spinal Muscular Atrophy Medicine Sales Market Share in Volume by Region (2024-2034)
Table 93. Asia-Pacific Spinal Muscular Atrophy Medicine Sales by Region (2024-2034) & (US$ Million)
Table 94. Asia-Pacific Spinal Muscular Atrophy Medicine Sales Market Share in Value by Region (2024-2034)
Table 95. Latin America Spinal Muscular Atrophy Medicine Sales by Country (2018-2024) & (K Pcs)
Table 96. Latin America Spinal Muscular Atrophy Medicine Sales Market Share in Volume by Country (2018-2024)
Table 97. Latin America Spinal Muscular Atrophy Medicine Sales by Country (2018-2024) & (US$ Million)
Table 98. Latin America Spinal Muscular Atrophy Medicine Sales Market Share in Value by Country (2018-2024)
Table 99. Latin America Spinal Muscular Atrophy Medicine Sales by Country (2024-2034) & (K Pcs)
Table 100. Latin America Spinal Muscular Atrophy Medicine Sales Market Share in Volume by Country (2024-2034)
Table 101. Latin America Spinal Muscular Atrophy Medicine Sales by Country (2024-2034) & (US$ Million)
Table 102. Latin America Spinal Muscular Atrophy Medicine Sales Market Share in Value by Country (2024-2034)
Table 103. Middle East and Africa Spinal Muscular Atrophy Medicine Sales by Country (2018-2024) & (K Pcs)
Table 104. Middle East and Africa Spinal Muscular Atrophy Medicine Sales Market Share in Volume by Country (2018-2024)
Table 105. Middle East and Africa Spinal Muscular Atrophy Medicine Sales by Country (2018-2024) & (US$ Million)
Table 106. Middle East and Africa Spinal Muscular Atrophy Medicine Sales Market Share in Value by Country (2018-2024)
Table 107. Middle East and Africa Spinal Muscular Atrophy Medicine Sales by Country (2024-2034) & (K Pcs)
Table 108. Middle East and Africa Spinal Muscular Atrophy Medicine Sales Market Share in Volume by Country (2024-2034)
Table 109. Middle East and Africa Spinal Muscular Atrophy Medicine Sales by Country (2024-2034) & (US$ Million)
Table 110. Middle East and Africa Spinal Muscular Atrophy Medicine Sales Market Share in Value by Country (2024-2034)
Table 111. Astellas Pharma Inc. Company Information
Table 112. Astellas Pharma Inc. Introduction and Business Overview
Table 113. Astellas Pharma Inc. Spinal Muscular Atrophy Medicine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 114. Astellas Pharma Inc. Spinal Muscular Atrophy Medicine Product
Table 115. Astellas Pharma Inc. Recent Development
Table 116. AveXis, Inc. Company Information
Table 117. AveXis, Inc. Introduction and Business Overview
Table 118. AveXis, Inc. Spinal Muscular Atrophy Medicine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 119. AveXis, Inc. Spinal Muscular Atrophy Medicine Product
Table 120. AveXis, Inc. Recent Development
Table 121. Bioblast Pharma Ltd. Company Information
Table 122. Bioblast Pharma Ltd. Introduction and Business Overview
Table 123. Bioblast Pharma Ltd. Spinal Muscular Atrophy Medicine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 124. Bioblast Pharma Ltd. Spinal Muscular Atrophy Medicine Product
Table 125. Bioblast Pharma Ltd. Recent Development
Table 126. Cytokinetics, Inc. 24 Company Information
Table 127. Cytokinetics, Inc. 24 Introduction and Business Overview
Table 128. Cytokinetics, Inc. 24 Spinal Muscular Atrophy Medicine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 129. Cytokinetics, Inc. 24 Spinal Muscular Atrophy Medicine Product
Table 130. Cytokinetics, Inc. 24 Recent Development
Table 131. F. Hoffmann-La Roche Ltd. Company Information
Table 132. F. Hoffmann-La Roche Ltd. Introduction and Business Overview
Table 133. F. Hoffmann-La Roche Ltd. Spinal Muscular Atrophy Medicine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 134. F. Hoffmann-La Roche Ltd. Spinal Muscular Atrophy Medicine Product
Table 135. F. Hoffmann-La Roche Ltd. Recent Development
Table 136. Genethon Company Information
Table 137. Genethon Introduction and Business Overview
Table 138. Genethon Spinal Muscular Atrophy Medicine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 139. Genethon Spinal Muscular Atrophy Medicine Product
Table 140. Genethon Recent Development
Table 141. Genzyme Corporation Company Information
Table 142. Genzyme Corporation Introduction and Business Overview
Table 143. Genzyme Corporation Spinal Muscular Atrophy Medicine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 144. Genzyme Corporation Spinal Muscular Atrophy Medicine Product
Table 145. Genzyme Corporation Recent Development
Table 146. GMP-Orphan SAS Company Information
Table 147. GMP-Orphan SAS Introduction and Business Overview
Table 148. GMP-Orphan SAS Spinal Muscular Atrophy Medicine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 149. GMP-Orphan SAS Spinal Muscular Atrophy Medicine Product
Table 150. GMP-Orphan SAS Recent Development
Table 151. Ionis Pharmaceuticals, Inc. Company Information
Table 152. Ionis Pharmaceuticals, Inc. Introduction and Business Overview
Table 153. Ionis Pharmaceuticals, Inc. Spinal Muscular Atrophy Medicine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 154. Ionis Pharmaceuticals, Inc. Spinal Muscular Atrophy Medicine Product
Table 155. Ionis Pharmaceuticals, Inc. Recent Development
Table 156. Longevity Biotech, Inc Company Information
Table 157. Longevity Biotech, Inc Introduction and Business Overview
Table 158. Longevity Biotech, Inc Spinal Muscular Atrophy Medicine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 159. Longevity Biotech, Inc Spinal Muscular Atrophy Medicine Product
Table 160. Longevity Biotech, Inc Recent Development
Table 161. Neurodyn Inc. Company Information
Table 162. Neurodyn Inc. Introduction and Business Overview
Table 163. Neurodyn Inc. Spinal Muscular Atrophy Medicine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 164. Neurodyn Inc. Spinal Muscular Atrophy Medicine Product
Table 165. Neurodyn Inc. Recent Development
Table 166. Neurotune AG Company Information
Table 167. Neurotune AG Introduction and Business Overview
Table 168. Neurotune AG Spinal Muscular Atrophy Medicine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 169. Neurotune AG Spinal Muscular Atrophy Medicine Product
Table 170. Neurotune AG Recent Development
Table 171. Novartis AG Company Information
Table 172. Novartis AG Introduction and Business Overview
Table 173. Novartis AG Spinal Muscular Atrophy Medicine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 174. Novartis AG Spinal Muscular Atrophy Medicine Product
Table 175. Novartis AG Recent Development
Table 176. Sarepta Therapeutics, Inc. Company Information
Table 177. Sarepta Therapeutics, Inc. Introduction and Business Overview
Table 178. Sarepta Therapeutics, Inc. Spinal Muscular Atrophy Medicine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 179. Sarepta Therapeutics, Inc. Spinal Muscular Atrophy Medicine Product
Table 180. Sarepta Therapeutics, Inc. Recent Development
Table 181. Voyager Therapeutics, Inc. Company Information
Table 182. Voyager Therapeutics, Inc. Introduction and Business Overview
Table 183. Voyager Therapeutics, Inc. Spinal Muscular Atrophy Medicine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 184. Voyager Therapeutics, Inc. Spinal Muscular Atrophy Medicine Product
Table 185. Voyager Therapeutics, Inc. Recent Development
Table 186. Vybion, Inc. Company Information
Table 187. Vybion, Inc. Introduction and Business Overview
Table 188. Vybion, Inc. Spinal Muscular Atrophy Medicine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 189. Vybion, Inc. Spinal Muscular Atrophy Medicine Product
Table 190. Vybion, Inc. Recent Development
Table 191. WAVE Life Sciences Ltd. Company Information
Table 192. WAVE Life Sciences Ltd. Introduction and Business Overview
Table 193. WAVE Life Sciences Ltd. Spinal Muscular Atrophy Medicine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 194. WAVE Life Sciences Ltd. Spinal Muscular Atrophy Medicine Product
Table 195. WAVE Life Sciences Ltd. Recent Development
Table 196. Key Raw Materials Lists
Table 197. Raw Materials Key Suppliers Lists
Table 198. Spinal Muscular Atrophy Medicine Market Trends
Table 199. Spinal Muscular Atrophy Medicine Market Drivers
Table 200. Spinal Muscular Atrophy Medicine Market Challenges
Table 201. Spinal Muscular Atrophy Medicine Market Restraints
Table 202. Spinal Muscular Atrophy Medicine Distributors List
Table 203. Spinal Muscular Atrophy Medicine Downstream Customers
Table 204. Research Programs/Design for This Report
Table 205. Key Data Information from Secondary Sources
Table 206. Key Data Information from Primary Sources
List of Figures
Figure 1. Spinal Muscular Atrophy Medicine Product Picture
Figure 2. Global Spinal Muscular Atrophy Medicine Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Spinal Muscular Atrophy Medicine Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Spinal Muscular Atrophy Medicine Sales Status and Outlook (2018-2034) & (K Pcs)
Figure 5. Product Picture of LMI-070
Figure 6. Global LMI-070 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 7. Product Picture of ND-602
Figure 8. Global ND-602 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 9. Product Picture of NT-1654
Figure 10. Global NT-1654 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 11. Product Picture of Nusinersen
Figure 12. Global Nusinersen Sales YoY Growth (2018-2034) & (K Pcs)
Figure 13. Product Picture of NXD-30001
Figure 14. Global NXD-30001 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 15. Product Picture of Others
Figure 16. Global Others Sales YoY Growth (2018-2034) & (K Pcs)
Figure 17. Global Spinal Muscular Atrophy Medicine Sales by Type (2018-2034) & (US$ Million)
Figure 18. Global Spinal Muscular Atrophy Medicine Sales Market Share by Type in 2022 & 2034
Figure 19. North America Spinal Muscular Atrophy Medicine Sales Market Share in Volume by Type in 2022
Figure 20. North America Spinal Muscular Atrophy Medicine Sales Market Share in Value by Type in 2022
Figure 21. Europe Spinal Muscular Atrophy Medicine Sales Market Share in Volume by Type in 2022
Figure 22. Europe Spinal Muscular Atrophy Medicine Sales Market Share in Value by Type in 2022
Figure 23. Asia-Pacific Spinal Muscular Atrophy Medicine Sales Market Share in Volume by Type in 2022
Figure 24. Asia-Pacific Spinal Muscular Atrophy Medicine Sales Market Share in Value by Type in 2022
Figure 25. Latin America Spinal Muscular Atrophy Medicine Sales Market Share in Volume by Type in 2022
Figure 26. Latin America Spinal Muscular Atrophy Medicine Sales Market Share in Value by Type in 2022
Figure 27. Middle East and Africa Spinal Muscular Atrophy Medicine Sales Market Share in Volume by Type in 2022
Figure 28. Middle East and Africa Spinal Muscular Atrophy Medicine Sales Market Share in Value by Type in 2022
Figure 29. The 5 and 10 Largest Manufacturers in the World: Market Share by Spinal Muscular Atrophy Medicine Sales in 2022
Figure 30. The 5 and 10 Largest Manufacturers in the World: Market Share by Spinal Muscular Atrophy Medicine Revenue in 2022
Figure 31. Spinal Muscular Atrophy Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 32. Product Picture of Hospital
Figure 33. Global Hospital Sales YoY Growth (2018-2034) & (K Pcs)
Figure 34. Product Picture of Clinic
Figure 35. Global Clinic Sales YoY Growth (2018-2034) & (K Pcs)
Figure 36. Product Picture of Others
Figure 37. Global Others Sales YoY Growth (2018-2034) & (K Pcs)
Figure 38. Global Spinal Muscular Atrophy Medicine Sales by Application (2018-2034) & (US$ Million)
Figure 39. Global Spinal Muscular Atrophy Medicine Sales Market Share by Application in 2022 & 2034
Figure 40. North America Spinal Muscular Atrophy Medicine Sales Market Share in Volume by Application in 2022
Figure 41. North America Spinal Muscular Atrophy Medicine Sales Market Share in Value by Application in 2022
Figure 42. Europe Spinal Muscular Atrophy Medicine Sales Market Share in Volume by Application in 2022
Figure 43. Europe Spinal Muscular Atrophy Medicine Sales Market Share in Value by Application in 2022
Figure 44. Asia-Pacific Spinal Muscular Atrophy Medicine Sales Market Share in Volume by Application in 2022
Figure 45. Asia-Pacific Spinal Muscular Atrophy Medicine Sales Market Share in Value by Application in 2022
Figure 46. Latin America Spinal Muscular Atrophy Medicine Sales Market Share in Volume by Application in 2022
Figure 47. Latin America Spinal Muscular Atrophy Medicine Sales Market Share in Value by Application in 2022
Figure 48. Middle East and Africa Spinal Muscular Atrophy Medicine Sales Market Share in Value by Application in 2022
Figure 49. Key Raw Materials Price
Figure 50. Spinal Muscular Atrophy Medicine Manufacturing Cost Structure
Figure 51. Spinal Muscular Atrophy Medicine Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries